IP Library Granted Patent US 11,685,956
Granted Patent B2
US 11,685,956 · App. 17/170,541 · Granted Jun 27, 2023

Methylation assay

Inventors: Graham P. Lidgard (Madison, WI); Michael J. Domanico (Madison, WI); Hatim Allawi (Middleton, WI); Hongzhi Zou (Middleton, WI)
Assignee: Exact Sciences Corporation
C12Q1/6886C12Q1/686C12Q1/6827C12Q2600/154
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,685,956
App. No.
17/170,541
Granted
Jun 27, 2023
Kind
B2
Abstract

A method for detecting a methylated genomic locus is provided. In certain embodiments, the method comprises: a) treating a nucleic acid sample that contains both unmethylated and methylated copies of a genomic locus with an agent that modifies cytosine to uracil to produce a treated nucleic acid; b) amplifying a product from the treated nucleic acid using a first primer and a second primer, wherein the first primer hybridizes to a site in the locus that contain methylcytosines and the amplifying preferentially amplifies the methylated copies of the genomic locus, to produce an amplified sample; and c) detecting the presence of amplified methylated copies of the genomic locus in the amplified sample using a flap assay that employs an invasive oligonucleotide having a 3′ terminal G or C nucleotide that corresponds to a site of methylation in the genomic locus.

Claims (29)

1. A reaction mixture comprising:

a) amplification reagents comprising a thermostable polymerase, nucleotides, a first primer and a second primer for amplifying a target genomic locus from a treated nucleic acid sample; wherein:

i. said first primer hybridizes to a methylated sequence in said locus and contains a 3′ terminal G or C nucleotide that corresponds to a methylated cytosine in said genomic locus; and

ii. said reagents preferentially amplify methylated copies of said genomic locus, to produce an amplified sample;

b) flap assay reagents comprising a flap endonuclease, a FRET cassette, and a flap oligonucleotide that comprises a G or C nucleotide at a position that corresponds to said methylated cytosine and wherein an invasive oligonucleotide distinct from the first primer is not included and wherein the first primer serves as an invasive oligonucleotide; and

c) said treated nucleic acid sample, wherein said treated nucleic acid sample is made by treating an initial nucleic acid sample comprising both methylated copies and unmethylated copies of said genomic locus with an agent that modifies unmethylated cytosine to uracil;

wherein said reaction mixture is characterized in that it can amplify and detect the presence of methylated copies of said genomic locus in said sample.

2. The reaction mixture of claim 1 , wherein said flap oligonucleotide comprises an internal G or C nucleotide at a position that corresponds to a second methylated cytosine in said genomic locus.

3. The reaction mixture of claim 1 , wherein said first primer comprises an internal G or C nucleotide at a position that corresponds to a second methylated cytosine in said genomic locus.

4. The reaction mixture of claim 1 , wherein said first and second primers both hybridize to a methylated sequence in said genomic locus.

5. A kit comprising:

a) PCR reagents that include a first primer and a second primer, where the first primer hybridizes to a methylated sequence in the genomic locus and contains a 3′ terminal G or C nucleotide that corresponds to a methylated cytosine in the methylated sequence; and

b) flap assay reagents comprising a flap endonuclease, a FRET cassette and a flap oligonucleotide that comprises a G or C nucleotide at a position that corresponds to said methylated cytosine and wherein an invasive oligonucleotide distinct from the first primer is not included and wherein the first primer serves as an invasive oligonucleotide.

6. The reaction mixture of claim 1 , wherein the target genomic locus is Vimentin.

7. The reaction mixture of claim 6 , wherein the methylated sequence in said locus comprises the nucleic acid sequence of SEQ ID NO:12.

8. The reaction mixture of claim 6 , wherein the first primer comprises the sequence of SEQ ID NO:13.

9. The reaction mixture of claim 6 , wherein the second primer comprises the sequence of SEQ ID NO:14.

10. The reaction mixture of claim 6 , wherein the flap oligonucleotide comprises the sequence of SEQ ID NO:15.

11. The reaction mixture of claim 1 , wherein

the first primer comprises the sequence of SEQ ID NO:13,

the second primer comprises the sequence of SEQ ID NO:14, and

the flap oligonucleotide comprises the sequence of SEQ ID NO:15.

12. The kit of claim 5 , wherein the methylated sequence is a methylated sequence to which the first primer hybridizes is a methylated sequence of Vimentin.

13. The kit of claim 12 , wherein the methylated sequence in said locus comprises the nucleic acid sequence of SEQ ID NO:12.

14. The kit of claim 12 , the first primer comprises the sequence of SEQ ID NO:13.

15. The kit of claim 12 , wherein the second primer comprises the sequence of SEQ ID NO:14.

16. The kit of claim 12 , wherein

the first primer comprises the sequence of SEQ ID NO:13, and

the second primer comprises the sequence of SEQ ID NO:14.

Assignments (5)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 69898/0249) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075288/0393 →
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
MERGER Recorded Nov 8, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 061692/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2021
From: LIDGARD, GRAHAM P.; DOMANICO, MICHAEL J.; ALLAWI, HATIM; ZOU, HONGZHI
To: EXACT SCIENCES CORPORATION
Reel/Frame 055187/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2021
From: EXACT SCIENCES CORPORATION
To: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
Reel/Frame 055187/0285 →
Continuity (4)
Continuation 16522500 · Jul 25, 2019
Continuation 14539841 · Nov 12, 2014
Continuation 12946745 · Nov 15, 2010
Related Publication 20210222255A1 · Jul 22, 2021